{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T13:33:54Z","timestamp":1789652034247,"version":"4.0.0"},"reference-count":249,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2017,2,23]],"date-time":"2017-02-23T00:00:00Z","timestamp":1487808000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIH\/NIMH","award":["MH087332"],"award-info":[{"award-number":["MH087332"]}]},{"name":"NIH\/NIMH","award":["MH104131"],"award-info":[{"award-number":["MH104131"]}]},{"name":"NIH\/NIMH","award":["MH105330"],"award-info":[{"award-number":["MH105330"]}]},{"name":"NIH\/NIMH","award":["MH081482"],"award-info":[{"award-number":["MH081482"]}]},{"name":"NIH\/NIDA","award":["DA02948"],"award-info":[{"award-number":["DA02948"]}]},{"name":"NIH\/NIDA","award":["DA026306"],"award-info":[{"award-number":["DA026306"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Sciences"],"abstract":"<jats:p>Multiple mechanisms appear to contribute to neuronal stress and injury underlying HIV-associated neurocognitive disorders (HAND), which occur despite the successful introduction of combination antiretroviral therapy (cART). Evidence is accumulating that components of cART can itself be neurotoxic upon long-term exposure. In addition, abuse of psychostimulants, such as methamphetamine (METH), seems to compromise antiretroviral therapy and aggravate HAND. However, the combined effect of virus and recreational and therapeutic drugs on the brain is still incompletely understood. However, several lines of evidence suggest a shared critical role of oxidative stress, compromised neuronal energy homeostasis and autophagy in promotion and prevention of neuronal dysfunction associated with HIV-1 infection, cART and psychostimulant use. In this review, we present a synopsis of recent work related to neuronal stress and injury induced by HIV infection, antiretrovirals (ARVs) and the highly addictive psychostimulant METH.<\/jats:p>","DOI":"10.3390\/brainsci7030025","type":"journal-article","created":{"date-parts":[[2017,2,23]],"date-time":"2017-02-23T11:45:01Z","timestamp":1487850301000},"page":"25","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Neuronal Stress and Injury Caused by HIV-1, cART and Drug Abuse: Converging Contributions to HAND"],"prefix":"10.3390","volume":"7","author":[{"given":"Ana","family":"Sanchez","sequence":"first","affiliation":[{"name":"Immunity and Pathogenesis Program, Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Kaul","sequence":"additional","affiliation":[{"name":"Immunity and Pathogenesis Program, Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA"},{"name":"Department of Psychiatry, University of California San Diego, San Diego, CA 92093, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2017,2,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJM199909303411406","article-title":"The aids epidemic\u2014Considerations for the 21st century","volume":"341","author":"Fauci","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/35073639","article-title":"The global impact of HIV\/AIDS","volume":"410","author":"Piot","year":"2001","journal-title":"Nature"},{"key":"ref_3","unstructured":"Fact Sheet November 2016. Available online: http:\/\/www.unaids.org\/en\/resources\/fact-sheet."},{"key":"ref_4","unstructured":"The Joint United Nations Programme on HIV\/AIDS (UNAIDS) Unaids Report on the Global Aids Epidemic 2013. Available online: http:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/UNAIDS_Global_Report_2013_en_1.pdf."},{"key":"ref_5","unstructured":"The Joint United Nations Programme on HIV\/AIDS (UNAIDS) Global Aids Response Progress Reporting 2015. Available online: http:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/JC2702_GARPR2015guidelines_en.pdf."},{"key":"ref_6","unstructured":"Centers for Disease Control and Prevention, Available online: https:\/\/www.cdc.gov\/hiv\/."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1212\/01.WNL.0000287431.88658.8b","article-title":"Updated research nosology for HIV-associated neurocognitive disorders","volume":"69","author":"Antinori","year":"2007","journal-title":"Neurology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.2741\/2860","article-title":"Hiv\u2018s double strike at the brain: Neuronal toxicity and compromised neurogenesis","volume":"13","author":"Kaul","year":"2008","journal-title":"Front. Biosci."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/ana.22053","article-title":"Human immunodeficiency virus-associated neurocognitive disorders: Mind the gap","volume":"67","author":"McArthur","year":"2010","journal-title":"Ann. Neurol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1212\/WNL.0b013e318200d727","article-title":"HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: Charter study","volume":"75","author":"Heaton","year":"2010","journal-title":"Neurology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrneurol.2016.27","article-title":"HIV-associated neurocognitive disorder\u2014Pathogenesis and prospects for treatment","volume":"12","author":"Saylor","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"ref_12","unstructured":"Drugs of Abuse, Available online: https:\/\/www.drugabuse.gov\/drugs-abuse."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-1-4615-2980-4_26","article-title":"Enhancement of HIV-1 replication by opiates and cocaine: The cytokine connection","volume":"335","author":"Peterson","year":"1993","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10461-005-9056-4","article-title":"Additive deleterious effects of methamphetamine dependence and immunosuppression on neuropsychological functioning in HIV infection","volume":"10","author":"Carey","year":"2006","journal-title":"AIDS Behav."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/QAI.0b013e318229ba41","article-title":"Neurocognitive impact of substance use in HIV infection","volume":"58","author":"Byrd","year":"2011","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2174\/157016212802138823","article-title":"Cocaine and HIV-1 interplay in CNS: Cellular and molecular mechanisms","volume":"10","author":"Buch","year":"2012","journal-title":"Curr. HIV Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2174\/157016212802138724","article-title":"HIV-1 gp120 and drugs of abuse: Interactions in the central nervous system","volume":"10","author":"Silverstein","year":"2012","journal-title":"Curr. HIV Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/B978-0-12-801284-0.00013-0","article-title":"Neurohiv and use of addictive substances","volume":"118","author":"Chang","year":"2014","journal-title":"Int. Rev. Neurobiol."},{"key":"ref_19","first-page":"967","article-title":"Interaction of drugs of abuse and microrna with HIV: A brief review","volume":"6","author":"Nair","year":"2015","journal-title":"Front. Microbiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1086\/433175","article-title":"The role of substance abuse in HIV disease progression: Reconciling differences from laboratory and epidemiologic investigations","volume":"41","author":"Kapadia","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1089\/apc.2006.20.502","article-title":"Methamphetamine use and sexual activity among HIV-infected patients in care\u2014San Francisco, 2004","volume":"20","author":"Mitchell","year":"2006","journal-title":"Aids Patient Care STDs"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1086\/381975","article-title":"Crystal methamphetamine, its analogues, and HIV infection: Medical and psychiatric aspects of a new epidemic","volume":"38","author":"Urbina","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10461-006-9152-0","article-title":"Drug use and medication adherence among HIV-1 infected individuals","volume":"11","author":"Hinkin","year":"2007","journal-title":"AIDS Behav."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1086\/379894","article-title":"Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy","volume":"188","author":"Ellis","year":"2003","journal-title":"J. Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1750-3639.2003.tb00019.x","article-title":"Changing patterns in the neuropathogenesis of HIV during the haart era","volume":"13","author":"Langford","year":"2003","journal-title":"Brain Pathol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1355617704101021","article-title":"Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons","volume":"10","author":"Rippeth","year":"2004","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1212\/01.wnl.0000240066.02404.e6","article-title":"Cognitive deficits and degeneration of interneurons in HIV+ methamphetamine users","volume":"67","author":"Chana","year":"2006","journal-title":"Neurology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF03033915","article-title":"Interactions of HIV and methamphetamine: Cellular and molecular mechanisms of toxicity potentiation","volume":"12","author":"Cadet","year":"2007","journal-title":"Neurotox. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40263-012-0018-x","article-title":"Csf penetration by antiretroviral drugs","volume":"27","author":"Eisfeld","year":"2013","journal-title":"CNS Drugs"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/cid\/ciu862","article-title":"Neurocognitive change in the era of HIV combination antiretroviral therapy: The longitudinal charter study","volume":"60","author":"Heaton","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s13365-010-0006-1","article-title":"HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: Differences in rates, nature, and predictors","volume":"17","author":"Heaton","year":"2011","journal-title":"J. Neurovirol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/QAD.0b013e328345889d","article-title":"Peripheral neuropathy in HIV: Prevalence and risk factors","volume":"25","author":"Evans","year":"2011","journal-title":"AIDS"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s13365-012-0119-9","article-title":"HIV peripheral neuropathy progression: Protection with glucose-lowering drugs?","volume":"18","author":"Evans","year":"2012","journal-title":"J. Neurovirol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1212\/WNL.0b013e3181d9ed09","article-title":"Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort","volume":"74","author":"Robertson","year":"2010","journal-title":"Neurology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/QAD.0000000000000538","article-title":"Could antiretroviral neurotoxicity play a role in the pathogenesis of cognitive impairment in treated HIV disease?","volume":"29","author":"Underwood","year":"2014","journal-title":"AIDS"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nrd1151","article-title":"Toxicity of antiretroviral therapy and implications for drug development","volume":"2","author":"Carr","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/ana.10401","article-title":"Fk506 is neuroprotective in a model of antiretroviral toxic neuropathy","volume":"53","author":"Keswani","year":"2003","journal-title":"Ann. Neurol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1445-5994.1995.tb02825.x","article-title":"The role of bronchoscopy in the diagnosis and treatment of pulmonary disease in HIV-infected patients","volume":"25","author":"Lewin","year":"1995","journal-title":"Aust. N. Z. J. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s13365-012-0120-3","article-title":"Antiretroviral neurotoxicity","volume":"18","author":"Robertson","year":"2012","journal-title":"J. Neurovirol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s13365-013-0227-1","article-title":"Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system","volume":"20","author":"Akay","year":"2014","journal-title":"J. Neurovirol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ana.410190602","article-title":"The aids dementia complex: I. Clinical features","volume":"19","author":"Navia","year":"1986","journal-title":"Ann. Neurol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1126\/science.3277272","article-title":"The brain in aids: Central nervous system HIV-1 infection and aids dementia complex","volume":"239","author":"Price","year":"1988","journal-title":"Science"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/35073667","article-title":"Pathways to neuronal injury and apoptosis in HIV-associated dementia","volume":"410","author":"Kaul","year":"2001","journal-title":"Nature"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1212\/WNL.56.2.257","article-title":"HIV-associated neurologic disease incidence changes: Multicenter aids cohort study, 1990\u20131998","volume":"56","author":"Sacktor","year":"2001","journal-title":"Neurology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1001\/archneur.1997.00550160054016","article-title":"Neurocognitive impairment is an independent risk factor for death in hiv infection. San Diego HIV neurobehavioral research center group","volume":"54","author":"Ellis","year":"1997","journal-title":"Arch. Neurol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1097\/00002030-200009080-00010","article-title":"Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid","volume":"14","author":"Cunningham","year":"2000","journal-title":"AIDS"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1212\/01.wnl.0000210477.63851.d3","article-title":"Variable benefit in neuropsychological function in HIV-infected haart-treated patients","volume":"66","author":"Cysique","year":"2006","journal-title":"Neurology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/01.qai.0000197077.64021.07","article-title":"Neuroactive antiretroviral drugs do not influence neurocognitive performance in less advanced hiv-infected patients responding to highly active antiretroviral therapy","volume":"41","author":"Giancola","year":"2006","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/01.wco.0000236614.51592.ca","article-title":"Influence of highly active antiretroviral therapy on persistence of HIV in the central nervous system","volume":"19","author":"Nath","year":"2006","journal-title":"Curr. Opin. Neurol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/13550280390194109","article-title":"Human immunodeficiency virus-associated dementia: An evolving disease","volume":"9","author":"McArthur","year":"2003","journal-title":"J. Neurovirol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11481-008-9143-1","article-title":"Neurodegeneration and ageing in the haart era","volume":"4","author":"Brew","year":"2009","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1089\/10872910252806126","article-title":"The clinical profile of end-stage aids in the era of highly active antiretroviral therapy","volume":"16","author":"Welch","year":"2002","journal-title":"AIDS Patient Care STDs"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/sj.cdd.4401623","article-title":"HIV-1 infection and aids: Consequences for the central nervous system","volume":"12","author":"Kaul","year":"2005","journal-title":"Cell Death Differ."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.virusres.2005.04.009","article-title":"Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus","volume":"111","author":"Rothenaigner","year":"2005","journal-title":"Virus Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1126\/science.276.5319.1629b","article-title":"Treating aids dementia [letter; comment]","volume":"276","author":"Lipton","year":"1997","journal-title":"Science"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2005.07.018","article-title":"Regulation of neural cell survival by HIV-1 infection","volume":"21","author":"Jones","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/00005072-198611000-00003","article-title":"Neuropathology of acquired immunodeficiency syndrome (AIDS): An autopsy review","volume":"45","author":"Petito","year":"1986","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ana.410420618","article-title":"Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. Hnrc group. The HIV neurobehavioral research center","volume":"42","author":"Masliah","year":"1997","journal-title":"Ann. Neurol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/ana.410380510","article-title":"Immunocytochemical quantitation of human immunodeficiency virus in the brain: Correlations with dementia","volume":"38","author":"Glass","year":"1995","journal-title":"Ann. Neurol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/00005072-199405000-00010","article-title":"Brain viral burden in HIV infection","volume":"53","author":"Achim","year":"1994","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0960-5428(06)80272-X","article-title":"Measurement of cns HIV burden and its association with neurologic damage","volume":"4","author":"Wiley","year":"1994","journal-title":"Adv. Neuroimmunol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-5728(96)00160-9","article-title":"Cellular localization of tumor necrosis factor mrna in neurological tissue from HIV-infected patients by combined reverse transcriptase\/polymerase chain reaction in situ hybridization and immunohistochemistry","volume":"74","author":"Wesselingh","year":"1997","journal-title":"J. Neuroimmunol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/ana.410290215","article-title":"Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: Relationship to clinical and neurological status","volume":"29","author":"Heyes","year":"1991","journal-title":"Ann. Neurol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00002030-200501030-00005","article-title":"Circulating proviral HIV DNA and HIV-associated dementia","volume":"19","author":"Shiramizu","year":"2005","journal-title":"AIDS"},{"key":"ref_65","first-page":"13","article-title":"HIV DNA and dementia in treatment-naive HIV-1-infected individuals in bangkok, thailand","volume":"4","author":"Shiramizu","year":"2006","journal-title":"Int. J. Med. Sci."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/BF00294228","article-title":"Loss of neurons in the frontal cortex in aids brains","volume":"80","author":"Ketzler","year":"1990","journal-title":"Acta Neuropathol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/0140-6736(91)92786-2","article-title":"Neuronal loss in the frontal cortex in HIV infection","volume":"337","author":"Everall","year":"1991","journal-title":"Lancet"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF00310921","article-title":"Nigral degeneration in acquired immune deficiency syndrome (AIDS)","volume":"82","author":"Reyes","year":"1991","journal-title":"Acta Neuropathol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1600-0404.1990.tb00945.x","article-title":"Subacute cerebellar syndrome as the first manifestation of aids dementia complex","volume":"81","author":"Graus","year":"1990","journal-title":"Acta Neurol. Scand."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00005072-199311000-00002","article-title":"A review of neuronal damage in human immunodeficiency virus infection: Its assessment, possible mechanism and relationship to dementia","volume":"52","author":"Everall","year":"1993","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1046\/j.1365-2990.1999.00167.x","article-title":"Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage","volume":"25","author":"Wingertsmann","year":"1999","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_72","first-page":"1121","article-title":"Evidence of apoptotic cell death in HIV encephalitis","volume":"146","author":"Petito","year":"1995","journal-title":"Am. J. Pathol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3109\/13550280009091954","article-title":"Nfkappab activation, TNF-alpha expression, and apoptosis in the aids-dementia-complex","volume":"6","author":"Rostasy","year":"2000","journal-title":"J. Neurovirol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/jnen\/64.6.529","article-title":"Influence of haart on HIV-related cns disease and neuroinflammation","volume":"64","author":"Anthony","year":"2005","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF03033819","article-title":"The shifting patterns of HIV encephalitis neuropathology","volume":"8","author":"Everall","year":"2005","journal-title":"Neurotox. Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/01.aids.0000161770.06158.5c","article-title":"Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients","volume":"19","author":"Green","year":"2005","journal-title":"AIDS"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJM198512123132401","article-title":"Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome","volume":"313","author":"Ho","year":"1985","journal-title":"N. Engl. J. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1126\/science.287.5453.602","article-title":"HIV infection and dementia","volume":"287","author":"Gartner","year":"2000","journal-title":"Science"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nri1527","article-title":"The neuropathogenesis of AIDS","volume":"5","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1126\/science.3016903","article-title":"Detection of aids virus in macrophages in brain tissue from aids patients with encephalopathy","volume":"233","author":"Koenig","year":"1986","journal-title":"Science"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/381667a0","article-title":"HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5","volume":"381","author":"Dragic","year":"1996","journal-title":"Nature"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/382833a0","article-title":"The CXC chemokine SDF-1 is the ligand for LESTR\/fusin and prevents infection by T-cell-line-adapted HIV-1","volume":"382","author":"Oberlin","year":"1996","journal-title":"Nature"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/385645a0","article-title":"CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia","volume":"385","author":"He","year":"1997","journal-title":"Nature"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0166-2236(99)01453-8","article-title":"Chemokines in the CNS: Plurifunctional mediators in diverse states","volume":"22","author":"Asensio","year":"1999","journal-title":"Trends Neurosci."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0166-2236(99)01408-3","article-title":"Aids and the brain: Is there a chemokine connection?","volume":"22","author":"Miller","year":"1999","journal-title":"Trends Neurosci."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0960-9822(98)70230-1","article-title":"Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1 alpha is mediated by the chemokine receptor CXCR4","volume":"8","author":"Hesselgesser","year":"1998","journal-title":"Curr. Biol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"14500","DOI":"10.1073\/pnas.95.24.14500","article-title":"Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity","volume":"95","author":"Meucci","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"8075","DOI":"10.1073\/pnas.090017497","article-title":"Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival","volume":"97","author":"Meucci","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"8212","DOI":"10.1073\/pnas.96.14.8212","article-title":"Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis","volume":"96","author":"Kaul","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/sj.cdd.4402006","article-title":"HIV-1 coreceptors CCR5 and CXCR4 both mediate neuronal cell death but CCR5 paradoxically can also contribute to protection","volume":"14","author":"Kaul","year":"2007","journal-title":"Cell Death Differ."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0165-5728(99)00049-1","article-title":"Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1-associated dementia","volume":"98","author":"Zheng","year":"1999","journal-title":"J. Neuroimmunol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.4049\/jimmunol.1302915","article-title":"CCR5 knockout prevents neuronal injury and behavioral impairment induced in a transgenic mouse model by a CXCR4-using HIV-1 glycoprotein 120","volume":"193","author":"Maung","year":"2014","journal-title":"J. Immunol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/335639a0","article-title":"Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide","volume":"335","author":"Brenneman","year":"1988","journal-title":"Nature"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1742-2094-1-7","article-title":"Human CNS cultures exposed to HIV-1 gp120 reproduce dendritic injuries of HIV-1-associated dementia","volume":"1","author":"Iskander","year":"2004","journal-title":"J. Neuroinflamm."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1742-2094-1-8","article-title":"Antioxidant protection from HIV-1 gp120-induced neuroglial toxicity","volume":"1","author":"Walsh","year":"2004","journal-title":"J. Neuroinflamm."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1128\/JVI.73.2.897-906.1999","article-title":"Apoptosis induced by infection of primary brain cultures with diverse human immunodeficiency virus type 1 isolates: Evidence for a role of the envelope","volume":"73","author":"Ohagen","year":"1999","journal-title":"J. Virol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"9407","DOI":"10.1128\/JVI.76.18.9407-9419.2002","article-title":"Development of a human neuronal cell model for human immunodeficiency virus (HIV)-infected macrophage-induced neurotoxicity: Apoptosis induced by HIV type 1 primary isolates and evidence for involvement of the Bcl-2\/Bcl-xl-sensitive intrinsic apoptosis pathway","volume":"76","author":"Chen","year":"2002","journal-title":"J. Virol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1096\/fj.04-1676fje","article-title":"HIV associated neurodegeneration requires p53 in neurons and microglia","volume":"18","author":"Garden","year":"2004","journal-title":"FASEB J."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/sj.cdd.4401577","article-title":"Cell death in HIV dementia","volume":"12","author":"Mattson","year":"2005","journal-title":"Cell Death Differ."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3109\/13550289709015806","article-title":"Human immunodeficiency virus type 1 tat protein induces death by apoptosis in primary human neuron cultures","volume":"3","author":"New","year":"1997","journal-title":"J. Neurovirol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1126\/science.274.5294.1917","article-title":"Immunologic no synthase: Elevation in severe aids dementia and induction by HIV-1 gp41","volume":"274","author":"Adamson","year":"1996","journal-title":"Science"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1073\/pnas.95.8.4595","article-title":"Extracellular HIV-1 virus protein r causes a large inward current and cell death in cultured hippocampal neurons: Implications for aids pathology","volume":"95","author":"Piller","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.4049\/jimmunol.163.3.1237","article-title":"HIV type 1 nef protein is a viral factor for leukocyte recruitment into the central nervous system","volume":"163","author":"Koedel","year":"1999","journal-title":"J. Immunol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrn2040","article-title":"HIV and antiretroviral therapy in the brain: Neuronal injury and repair","volume":"8","author":"Ellis","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1086\/422008","article-title":"HIV-1 promotes quiescence in human neural progenitor cells","volume":"190","author":"Krathwohl","year":"2004","journal-title":"J. Infect. Dis."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.stem.2007.07.010","article-title":"HIV\/gp120 decreases adult neural progenitor cell proliferation via checkpoint kinase-mediated cell-cycle withdrawal and G1 arrest","volume":"1","author":"Okamoto","year":"2007","journal-title":"Cell Stem Cell"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1126\/science.2148832","article-title":"Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1","volume":"250","author":"Giulian","year":"1990","journal-title":"Science"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1084\/jem.176.6.1703","article-title":"Cytokines and arachidonic metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: Implications for the neuropathogenesis of HIV disease","volume":"176","author":"Genis","year":"1992","journal-title":"J. Exp. Med."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.4049\/jimmunol.0902535","article-title":"Activation of p38 mapk is required in monocytic and neuronal cells for HIV glycoprotein 120-induced neurotoxicity","volume":"185","author":"Medders","year":"2010","journal-title":"J. Immunol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"702","DOI":"10.4049\/jimmunol.177.1.702","article-title":"Inhibition of mixed lineage kinase 3 prevents HIV-1 tat-mediated neurotoxicity and monocyte activation","volume":"177","author":"Sui","year":"2006","journal-title":"J. Immunol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1073\/pnas.90.7.2769","article-title":"The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes","volume":"90","author":"Giulian","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1126\/science.2326646","article-title":"HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists","volume":"248","author":"Dreyer","year":"1990","journal-title":"Science"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1523\/JNEUROSCI.4617-05.2006","article-title":"Human immunodeficiency virus (HIV)-induced neurotoxicity: Roles for the nmda receptor subtypes","volume":"26","author":"Agrawal","year":"2006","journal-title":"J. Neurosci."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1126\/science.1835799","article-title":"Nmda antagonist neurotoxicity: Mechanism and prevention","volume":"254","author":"Olney","year":"1991","journal-title":"Science"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0163-7258(98)00042-4","article-title":"The role of excitotoxicity in neurodegenerative disease: Implications for therapy","volume":"81","author":"Doble","year":"1999","journal-title":"Pharmacol. Ther."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1126\/science.164.3880.719","article-title":"Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate","volume":"164","author":"Olney","year":"1969","journal-title":"Science"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1046\/j.1471-4159.1998.71030946.x","article-title":"Role of caspases in N-methyl-d-aspartate-induced apoptosis in cerebrocortical neurons","volume":"71","author":"Tenneti","year":"1998","journal-title":"J. Neurochem."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1523\/JNEUROSCI.22-10-04015.2002","article-title":"Caspase cascades in human immunodeficiency virus-associated neurodegeneration","volume":"22","author":"Garden","year":"2002","journal-title":"J. Neurosci."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1523\/JNEUROSCI.22-06-02185.2002","article-title":"Cell cycle proteins exhibit altered expression patterns in lentiviral-associated encephalitis","volume":"22","author":"Wang","year":"2002","journal-title":"J. Neurosci."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"9531","DOI":"10.1523\/JNEUROSCI.3085-04.2004","article-title":"Human immunodeficiency virus type 1 gp120 induces apoptosis in human primary neurons through redox-regulated activation of neutral sphingomyelinase","volume":"24","author":"Jana","year":"2004","journal-title":"J. Neurosci."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1097\/00126334-200210012-00005","article-title":"Calcium dysregulation and neuronal apoptosis by the HIV-1 proteins tat and gp120","volume":"31","author":"Haughey","year":"2002","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/ana.10828","article-title":"Perturbation of sphingolipid metabolism and ceramide production in HIV-dementia","volume":"55","author":"Haughey","year":"2004","journal-title":"Ann. Neurol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1365-2990.2007.00866.x","article-title":"Expression of the endoplasmic reticulum stress response marker, BiP, in the central nervous system of HIV-positive individuals","volume":"33","author":"Lindl","year":"2007","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_124","unstructured":"Federally Approved HIV\/AIDS Medical Practice Guidelines, Available online: https:\/\/aidsinfo.nih.gov\/guidelines."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s12640-016-9646-0","article-title":"Neurotoxicity in the post-haart era: Caution for the antiretroviral therapeutics","volume":"30","author":"Shah","year":"2016","journal-title":"Neurotox. Res."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s40121-016-0126-x","article-title":"New antiretroviral treatment for HIV","volume":"5","author":"Badowski","year":"2016","journal-title":"Infect. Dis. Ther."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1212\/WNL.0b013e31821670fb","article-title":"Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients","volume":"76","author":"Ciccarelli","year":"2011","journal-title":"Neurology"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-0034-1372340","article-title":"HIV and aging: Effects on the central nervous system","volume":"34","author":"Canizares","year":"2014","journal-title":"Semin. Neurol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s11065-015-9305-x","article-title":"Aging with HIV-1 infection: Motor functions, cognition, and attention\u2014A comparison with parkinson\u2019s disease","volume":"25","author":"DeVaughn","year":"2015","journal-title":"Neuropsychol. Rev."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s13365-015-0382-7","article-title":"Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients","volume":"22","author":"Ma","year":"2016","journal-title":"J. Neurovirol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nm0595-417","article-title":"Mitochondrial toxicity of antiviral drugs","volume":"1","author":"Lewis","year":"1995","journal-title":"Nat. Med."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1086\/593022","article-title":"Toxicities associated with dual nucleoside reverse-transcriptase inhibitor regimens in hiv-infected children","volume":"198","author":"Wang","year":"2008","journal-title":"J. Infect. Dis."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.2174\/138161211796904731","article-title":"Mitochondrial toxicity in haart: An overview of in vitro evidence","volume":"17","author":"Apostolova","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/0140-6736(91)91294-5","article-title":"Depletion of muscle mitochondrial DNA in aids patients with zidovudine-induced myopathy","volume":"337","author":"Arnaudo","year":"1991","journal-title":"Lancet"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00126334-200207010-00002","article-title":"Exposure to dideoxynucleosides is reflected in lowered mitochondrial DNA in subcutaneous fat","volume":"30","author":"Cherry","year":"2002","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMoa012035","article-title":"Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients","volume":"346","author":"Cote","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/infdis\/jiu273","article-title":"Neuronal bioenergetics and acute mitochondrial dysfunction: A clue to understanding the central nervous system side effects of efavirenz","volume":"210","author":"Funes","year":"2014","journal-title":"J. Infect. Dis."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.bbrc.2014.06.098","article-title":"Down-regulation of mitochondrial thymidine kinase 2 and deoxyguanosine kinase by didanosine: Implication for mitochondrial toxicities of anti-HIV nucleoside analogs","volume":"450","author":"Sun","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Song, F., Gao, Z., Ding, W., Qiao, L., Yang, S., Chen, X., Jin, R., and Chen, D. (2014). Long-term exposure of mice to nucleoside analogues disrupts mitochondrial DNA maintenance in cortical neurons. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0085637"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/095632020301400507","article-title":"Nucleoside reverse transcriptase inhibitor usage and the incidence of peripheral neuropathy in HIV\/AIDS patients","volume":"14","author":"Dragovic","year":"2003","journal-title":"Antivir. Chem. Chemother."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1046\/j.1529-8027.2001.006001014.x","article-title":"Peripheral neuropathy and antiretroviral drugs","volume":"6","author":"Dalakas","year":"2001","journal-title":"J. Peripher. Nerv. Syst."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/QAD.0b013e328335cdea","article-title":"Oral uridine supplementation antagonizes the peripheral neuropathy and encephalopathy induced by antiretroviral nucleoside analogues","volume":"24","author":"Venhoff","year":"2010","journal-title":"AIDS"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00126334-200006010-00003","article-title":"Genotoxic and functional consequences of transplacental zidovudine exposure in fetal monkey brain mitochondria","volume":"24","author":"Ewings","year":"2000","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1038\/sj.onc.1203596","article-title":"Fibroblast growth factor 2 up regulates telomerase activity in neural precursor cells","volume":"19","author":"Haik","year":"2000","journal-title":"Oncogene"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1128\/AAC.01632-15","article-title":"Antiretrovirals, methamphetamine, and HIV-1 envelope protein gp120 compromise neuronal energy homeostasis in association with various degrees of synaptic and neuritic damage","volume":"60","author":"Sanchez","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3851\/IMP2982","article-title":"Antiretroviral activity and safety of once-daily etravirine in treatment-naive HIV-infected adults: 48-week results","volume":"21","author":"Mollan","year":"2016","journal-title":"Antivir. Ther."},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Brown, L.A., Jin, J., Ferrell, D., Sadic, E., Obregon, D., Smith, A.J., Tan, J., and Giunta, B. (2014). Efavirenz promotes beta-secretase expression and increased abeta1\u201340,42 via oxidative stress and reduced microglial phagocytosis: Implications for hiv associated neurocognitive disorders (hand). PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0095500"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1517\/14740338.2013.823396","article-title":"Neuronal toxicity of efavirenz: A systematic review","volume":"12","author":"Decloedt","year":"2013","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1124\/jpet.114.217869","article-title":"Efavirenz induces neuronal autophagy and mitochondrial alterations","volume":"351","author":"Purnell","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1093\/jac\/dku262","article-title":"Lack of mitochondrial toxicity of darunavir, raltegravir and rilpivirine in neurons and hepatocytes: A comparison with efavirenz","volume":"69","author":"Polo","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1124\/mol.115.098590","article-title":"Dysregulation of endoplasmic reticulum stress and autophagic responses by the antiretroviral drug efavirenz","volume":"88","author":"Bertrand","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1086\/522175","article-title":"Successful efavirenz dose reduction in HIV type 1-infected individuals with cytochrome p450 2b6 *6 and *26","volume":"45","author":"Gatanaga","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"ref_153","unstructured":"Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents, Available online: http:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/AdultandAdolescentGL.pdf."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/00126334-200003010-00004","article-title":"Incidence of adverse reactions in HIV patients treated with protease inhibitors: A cohort study. Coordinamento italiano studio allergia e infezione da HIV (CISAI) group","volume":"23","author":"Bonfanti","year":"2000","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.tips.2004.02.007","article-title":"Pharmacogenetics of cytochrome p450 and its applications in drug therapy: The past, present and future","volume":"25","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s13365-014-0251-9","article-title":"Pattern of neurocognitive function in patients receiving boosted protease inhibitor monotherapy: A detailed neuropsychological study","volume":"20","author":"Carvajal","year":"2014","journal-title":"J. Neurovirol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1345\/aph.1A251","article-title":"Central nervous system toxicity and amprenavir oral solution","volume":"36","author":"James","year":"2002","journal-title":"Ann. Pharmacother."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/ana.20816","article-title":"Sensory neuropathy in human immunodeficiency virus\/acquired immunodeficiency syndrome patients: Protease inhibitor-mediated neurotoxicity","volume":"59","author":"Pettersen","year":"2006","journal-title":"Ann. Neurol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/QAD.0000000000000955","article-title":"HIV protease inhibitors disrupt astrocytic glutamate transporter function and neurobehavioral performance","volume":"30","author":"Vivithanaporn","year":"2016","journal-title":"AIDS"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ajpath.2016.09.006","article-title":"HIV protease inhibitors alter amyloid precursor protein processing via beta-site amyloid precursor protein cleaving enzyme-1 translational up-regulation","volume":"187","author":"Gannon","year":"2017","journal-title":"Am. J. Pathol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"F7","DOI":"10.1097\/QAD.0b013e328345766f","article-title":"Randomized, phase 2 evaluation of two single-tablet regimens elvitegravir\/cobicistat\/ emtricitabine\/tenofovir disoproxil fumarate versus efavirenz\/emtricitabine\/tenofovir disoproxil fumarate for the initial treatment of HIV infection","volume":"25","author":"Cohen","year":"2011","journal-title":"AIDS"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1097\/QAD.0b013e32830e0169","article-title":"Exacerbation of depression associated with starting raltegravir: A report of four cases","volume":"22","author":"Harris","year":"2008","journal-title":"AIDS"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2174\/157016211794582650","article-title":"Long-term safety from the raltegravir clinical development program","volume":"9","author":"Teppler","year":"2011","journal-title":"Curr. HIV Res."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0149-2918(04)90032-X","article-title":"Enfuvirtide: A fusion inhibitor for the treatment of hiv infection","volume":"26","author":"Fung","year":"2004","journal-title":"Clin. Ther."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1056\/NEJMoa035026","article-title":"Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in north and South America","volume":"348","author":"Lalezari","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1089\/aid.2007.0300","article-title":"A report on the effect of commencing enfuvirtide on peripheral neuropathy","volume":"24","author":"Cherry","year":"2008","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1056\/NEJMoa035211","article-title":"Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in europe and australia","volume":"348","author":"Lazzarin","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/jac\/dkr427","article-title":"CNS effects of a CCR5 inhibitor in HIV-infected subjects: A pharmacokinetic and cerebral metabolite study","volume":"67","author":"Garvey","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/COH.0b013e328356e933","article-title":"Clinical studies with chemokine receptor-5 (CCR5)-inhibitors","volume":"7","author":"Boesecke","year":"2012","journal-title":"Curr. Opin. HIV AIDS"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"F21","DOI":"10.1097\/QAD.0000000000000074","article-title":"Neuroprotective maraviroc monotherapy in simian immunodeficiency virus-infected macaques: Reduced replicating and latent SIV in the brain","volume":"27","author":"Kelly","year":"2013","journal-title":"AIDS"},{"key":"ref_171","first-page":"1388","article-title":"Contrasting cytokine profiles in the synovium of different forms of juvenile rheumatoid arthritis and juvenile spondyloarthropathy: Prominence of interleukin 4 in restricted disease","volume":"25","author":"Murray","year":"1998","journal-title":"J. Rheumatol."},{"key":"ref_172","first-page":"301","article-title":"The need for speed: An update on methamphetamine addiction","volume":"31","author":"Barr","year":"2006","journal-title":"J. Psychiatry Neurosci."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/j.1360-0443.2007.01874.x","article-title":"Methamphetamine and cardiovascular pathology: A review of the evidence","volume":"102","author":"Kaye","year":"2007","journal-title":"Addiction"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"5756","DOI":"10.1523\/JNEUROSCI.1179-08.2008","article-title":"Methamphetamine causes microglial activation in the brains of human abusers","volume":"28","author":"Sekine","year":"2008","journal-title":"J. Neurosci."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00213-007-0825-9","article-title":"Pharmacological and behavioral determinants of cocaine, methamphetamine, 3,4-methylenedioxymethamphetamine, and para-methoxyamphetamine-induced hyperthermia","volume":"194","author":"Jaehne","year":"2007","journal-title":"Psychopharmacology"},{"key":"ref_176","first-page":"214","article-title":"Methamphetamine and the expanding complications of amphetamines","volume":"170","author":"Albertson","year":"1999","journal-title":"West. J. Med."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/00223989809599162","article-title":"Psychophysiological aspects of amphetamine-methamphetamine abuse","volume":"132","author":"Murray","year":"1998","journal-title":"J. Psychol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11065-007-9031-0","article-title":"Neurocognitive effects of methamphetamine: A critical review and meta-analysis","volume":"17","author":"Scott","year":"2007","journal-title":"Neuropsychol. Rev."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2174\/157016207780636515","article-title":"Progress in understanding basal ganglia dysfunction as a common target for methamphetamine abuse and HIV-1 neurodegeneration","volume":"5","author":"Theodore","year":"2007","journal-title":"Curr. HIV Res."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00005082-199206020-00004","article-title":"Cardiovascular effects of methamphetamine","volume":"6","author":"Lynch","year":"1992","journal-title":"J. Cardiovasc. Nurs."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0736-4679(99)00009-8","article-title":"Methamphetamine-related stroke: Four cases","volume":"17","author":"Perez","year":"1999","journal-title":"J. Emerg. Med."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"8417","DOI":"10.1523\/JNEUROSCI.18-20-08417.1998","article-title":"Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: Evidence from positron emission tomography studies with [11c]win-35,428","volume":"18","author":"McCann","year":"1998","journal-title":"J. Neurosci."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nm0696-699","article-title":"Striatal dopamine nerve terminal markers in human, chronic methamphetamine users","volume":"2","author":"Wilson","year":"1996","journal-title":"Nat. Med."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1176\/appi.ajp.158.12.2015","article-title":"Low level of brain dopamine d2 receptors in methamphetamine abusers: Association with metabolism in the orbitofrontal cortex","volume":"158","author":"Volkow","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1001\/archpsyc.63.1.90","article-title":"Brain serotonin transporter density and aggression in abstinent methamphetamine abusers","volume":"63","author":"Sekine","year":"2006","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1176\/appi.ajp.158.3.383","article-title":"Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers","volume":"158","author":"Volkow","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0022-3565(24)36396-7","article-title":"Decreases in evoked overflow of dopamine in rat striatum after neurotoxic doses of methamphetamine","volume":"280","author":"Cass","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"6028","DOI":"10.1523\/JNEUROSCI.0713-04.2004","article-title":"Structural abnormalities in the brains of human subjects who use methamphetamine","volume":"24","author":"Thompson","year":"2004","journal-title":"J. Neurosci."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1471-4159.2004.02906.x","article-title":"Attenuated microglial activation mediates tolerance to the neurotoxic effects of methamphetamine","volume":"92","author":"Thomas","year":"2005","journal-title":"J. Neurochem."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0006-8993(82)90198-6","article-title":"Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain","volume":"235","author":"Ricaurte","year":"1982","journal-title":"Brain Res."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/0006-8993(89)90562-3","article-title":"Selective reduction of serotonin immunoreactivity in some forebrain regions of rats induced by acute methamphetamine treatment; quantitative morphometric analysis by serotonin immunocytochemistry","volume":"482","author":"Fukui","year":"1989","journal-title":"Brain Res."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0022-3565(25)32165-8","article-title":"Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain","volume":"214","author":"Hotchkiss","year":"1980","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0006-8993(80)91265-2","article-title":"Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine","volume":"181","author":"Wagner","year":"1980","journal-title":"Brain Res."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0006-8993(93)91712-2","article-title":"Long-lasting decrease in dopamine uptake sites following repeated administration of methamphetamine in the rat striatum","volume":"601","author":"Nakayama","year":"1993","journal-title":"Brain Res."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0006-8993(95)00218-F","article-title":"Methamphetamine-induced serotonin neurotoxicity is mediated by superoxide radicals","volume":"677","author":"Hirata","year":"1995","journal-title":"Brain Res."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0006-8993(99)02087-9","article-title":"Methamphetamine administration causes overexpression of nnos in the mouse striatum","volume":"851","author":"Deng","year":"1999","journal-title":"Brain Res."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0014-2999(97)01152-7","article-title":"Reduced striatal vesicular monoamine transporters after neurotoxic but not after behaviorally-sensitizing doses of methamphetamine","volume":"334","author":"Frey","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/(SICI)1098-2396(199812)30:4<433::AID-SYN10>3.0.CO;2-O","article-title":"Methamphetamine neurotoxicity: Dissociation of striatal dopamine terminal damage from parietal cortical cell body injury","volume":"30","author":"Eisch","year":"1998","journal-title":"Synapse"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/(SICI)1098-2396(200007)37:1<32::AID-SYN4>3.0.CO;2-X","article-title":"Repeated administration of methamphetamine damages cells in the somatosensory cortex: Overlap with cytochrome oxidase-rich barrels","volume":"37","author":"Marshall","year":"2000","journal-title":"Synapse"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0006-8993(97)00173-X","article-title":"Methamphetamine exposure can produce neuronal degeneration in mouse hippocampal remnants","volume":"759","author":"Schmued","year":"1997","journal-title":"Brain Res."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.biopsych.2006.09.010","article-title":"Methamphetamine administration causes death of dopaminergic neurons in the mouse olfactory bulb","volume":"61","author":"Deng","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1073\/pnas.0404990102","article-title":"Calcineurin\/NFAT-induced up-regulation of the Fas ligand\/Fas death pathway is involved in methamphetamine-induced neuronal apoptosis","volume":"102","author":"Jayanthi","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.1523\/JNEUROSCI.4893-04.2005","article-title":"Neuropeptide y protects against methamphetamine-induced neuronal apoptosis in the mouse striatum","volume":"25","author":"Thiriet","year":"2005","journal-title":"J. Neurosci."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1146\/annurev.pa.33.040193.003231","article-title":"Amphetamine: Effects on catecholamine systems and behavior","volume":"33","author":"Seiden","year":"1993","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1111\/j.1471-4159.1993.tb07476.x","article-title":"Functional identification and molecular cloning of a human brain vesicle monoamine transporter","volume":"61","author":"Erickson","year":"1993","journal-title":"J. Neurochem."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.pneurobio.2005.04.003","article-title":"Mechanisms of neurotransmitter release by amphetamines: A review","volume":"75","author":"Sulzer","year":"2005","journal-title":"Prog. Neurobiol."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0006-8993(92)90713-J","article-title":"Methamphetamine neurotoxicity and striatal glutamate release: Comparison to 3,4-methylenedioxymethamphetamine","volume":"581","author":"Nash","year":"1992","journal-title":"Brain Res."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S1567-5769(02)00047-4","article-title":"Chronic methamphetamine exposure alters immune function in normal and retrovirus-infected mice","volume":"2","author":"Yu","year":"2002","journal-title":"Int. Immunopharmacol."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1080\/15287390500177156","article-title":"Methamphetamine administration produces immunomodulation in mice","volume":"68","author":"In","year":"2005","journal-title":"J. Toxicol. Environ. Health A"},{"key":"ref_210","doi-asserted-by":"crossref","unstructured":"Talloczy, Z., Martinez, J., Joset, D., Ray, Y., Gacser, A., Toussi, S., Mizushima, N., Nosanchuk, J., Goldstein, H., and Loike, J. (2008). Methamphetamine inhibits antigen processing, presentation, and phagocytosis. PLoS Pathog., 4.","DOI":"10.1371\/annotation\/bd02ad26-a081-4c61-88c2-ebda285b8bca"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.brainresrev.2009.03.002","article-title":"Methamphetamine toxicity and messengers of death","volume":"60","author":"Krasnova","year":"2009","journal-title":"Brain Res. Rev."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"e850","DOI":"10.1038\/cddis.2013.374","article-title":"HIV gp120- and methamphetamine-mediated oxidative stress induces astrocyte apoptosis via cytochrome p450 2e1","volume":"4","author":"Shah","year":"2013","journal-title":"Cell Death Dis."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1007\/s00125-012-2648-4","article-title":"Modulation of gut microbiota by antibiotics improves insulin signalling in high-Fat fed mice","volume":"55","author":"Carvalho","year":"2012","journal-title":"Diabetologia"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.disamonth.2011.09.004","article-title":"Methamphetamine: History, pathophysiology, adverse health effects, current trends, and hazards associated with the clandestine manufacture of methamphetamine","volume":"58","author":"Vearrier","year":"2012","journal-title":"Dis. Mon."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1196\/annals.1369.022","article-title":"Methamphetamine induces autophagy and apoptosis in a mesencephalic dopaminergic neuronal culture model: Role of cathepsin-D in methamphetamine-induced apoptotic cell death","volume":"1074","author":"Kanthasamy","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"8951","DOI":"10.1523\/JNEUROSCI.22-20-08951.2002","article-title":"Methamphetamine-induced degeneration of dopaminergic neurons involves autophagy and upregulation of dopamine synthesis","volume":"22","author":"Larsen","year":"2002","journal-title":"J. Neurosci."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1196\/annals.1432.016","article-title":"Role of autophagy during methamphetamine neurotoxicity","volume":"1139","author":"Pasquali","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"103969","DOI":"10.1155\/2015\/103969","article-title":"Recent advances in methamphetamine neurotoxicity mechanisms and its molecular pathophysiology","volume":"2015","author":"Yu","year":"2015","journal-title":"Behav. Neurol."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s11481-016-9699-0","article-title":"Effects of hiv and methamphetamine on brain and behavior: Evidence from human studies and animal models","volume":"11","author":"Soontornniyomkij","year":"2016","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/09540120802385579","article-title":"Methamphetamine use, sexual activity, patient-provider communication, and medication adherence among HIV-infected patients in care, San Francisco 2004\u20132006","volume":"21","author":"Marquez","year":"2009","journal-title":"AIDS Care"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/00126334-200312150-00004","article-title":"Patterns of selective neuronal damage in methamphetamine-user AIDS patients","volume":"34","author":"Langford","year":"2003","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jneumeth.2009.11.007","article-title":"Alteration of methamphetamine-induced stereotypic behaviour in transgenic mice expressing HIV-1 envelope protein gp120","volume":"186","author":"Roberts","year":"2010","journal-title":"J. Neurosci. Methods"},{"key":"ref_223","doi-asserted-by":"crossref","unstructured":"Pendyala, G., Buescher, J.L., and Fox, H.S. (2012). Methamphetamine and inflammatory cytokines increase neuronal na+\/k+-atpase isoform 3: Relevance for HIV associated neurocognitive disorders. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0037604"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"900","DOI":"10.3389\/fmicb.2015.00900","article-title":"Phenotypic changes in the brain of SIV-infected macaques exposed to methamphetamine parallel macrophage activation patterns induced by the common gamma-chain cytokine system","volume":"6","author":"Bortell","year":"2015","journal-title":"Front. Microbiol."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.expneurol.2014.09.010","article-title":"Combination of methamphetamine and HIV-1 gp120 causes distinct long-term alterations of behavior, gene expression, and injury in the central nervous system","volume":"263","author":"Hoefer","year":"2015","journal-title":"Exp. Neurol."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"15294","DOI":"10.1073\/pnas.261560998","article-title":"Different responses of astrocytes and neurons to nitric oxide: The role of glycolytically generated atp in astrocyte protection","volume":"98","author":"Almeida","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/ncb1080","article-title":"Nitric oxide switches on glycolysis through the AMP protein kinase and 6-phosphofructo-2-kinase pathway","volume":"6","author":"Almeida","year":"2004","journal-title":"Nat. Cell Biol."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.bbadis.2016.11.017","article-title":"Mitochondrial defects arise from nucleoside\/nucleotide reverse transcriptase inhibitors in neurons: Potential contribution to HIV-associated neurocognitive disorders","volume":"1863","author":"Hung","year":"2017","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/0166-2236(89)90165-3","article-title":"Cytochrome oxidase: An endogenous metabolic marker for neuronal activity","volume":"12","year":"1989","journal-title":"Trends Neurosci."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.neuron.2014.10.019","article-title":"Axonal transport: Cargo-specific mechanisms of motility and regulation","volume":"84","author":"Maday","year":"2014","journal-title":"Neuron"},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cub.2012.02.005","article-title":"Spatial parkin translocation and degradation of damaged mitochondria via mitophagy in live cortical neurons","volume":"22","author":"Cai","year":"2012","journal-title":"Curr. Biol."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3389\/fgene.2012.00297","article-title":"Mitophagy in neurodegeneration and aging","volume":"3","author":"Palikaras","year":"2012","journal-title":"Front. Genet."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","article-title":"The roles of PINK1, parkin, and mitochondrial fidelity in parkinson\u2019s disease","volume":"85","author":"Pickrell","year":"2015","journal-title":"Neuron"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1101\/gad.17420111","article-title":"Amp-activated protein kinase: An energy sensor that regulates all aspects of cell function","volume":"25","author":"Hardie","year":"2011","journal-title":"Genes Dev."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1126\/science.1200094","article-title":"Ampk is a direct adenylate charge-regulated protein kinase","volume":"332","author":"Oakhill","year":"2011","journal-title":"Science"},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"Mtor signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature06639","article-title":"Autophagy fights disease through cellular self-digestion","volume":"451","author":"Mizushima","year":"2008","journal-title":"Nature"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s13365-012-0145-7","article-title":"Age-dependent molecular alterations in the autophagy pathway in hive patients and in a gp120 tg mouse model: Reversal with beclin-1 gene transfer","volume":"19","author":"Fields","year":"2013","journal-title":"J. Neurovirol."},{"key":"ref_239","doi-asserted-by":"crossref","unstructured":"Balgi, A.D., Fonseca, B.D., Donohue, E., Tsang, T.C., Lajoie, P., Proud, C.G., Nabi, I.R., and Roberge, M. (2009). Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mtorc1 signaling. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0007124"},{"key":"ref_240","first-page":"103","article-title":"Interactions of opioids and hiv infection in the pathogenesis of chronic pain","volume":"7","author":"Liu","year":"2016","journal-title":"Front. Microbiol."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1080\/13550280701528684","article-title":"Cocaine-mediated enhancement of virus replication in macrophages: Implications for human immunodeficiency virus-associated dementia","volume":"13","author":"Dhillon","year":"2007","journal-title":"J. Neurovirol."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.2353\/ajpath.2008.070971","article-title":"Methamphetamine enhances hiv infection of macrophages","volume":"172","author":"Liang","year":"2008","journal-title":"Am. J. Pathol."},{"key":"ref_243","doi-asserted-by":"crossref","unstructured":"Wang, Y., Wang, X., Ye, L., Li, J., Song, L., Fulambarkar, N., and Ho, W. (2012). Morphine suppresses IFN signaling pathway and enhances AIDS virus infection. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0031167"},{"key":"ref_244","first-page":"20","article-title":"Inhibition of interferon response by cystatin b: Implication in hiv replication of macrophage reservoirs","volume":"18","author":"Colon","year":"2011","journal-title":"J. Neurovirol."},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s11481-012-9356-1","article-title":"Do opioids activate latent HIV-1 by down-regulating anti-HIV micrornas?","volume":"7","author":"Purohit","year":"2012","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s13365-014-0238-6","article-title":"Exosomes and their role in CNS viral infections","volume":"20","author":"Sampey","year":"2014","journal-title":"J. Neurovirol."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"e381","DOI":"10.1038\/cddis.2012.114","article-title":"Exosome-mediated shuttling of microrna-29 regulates HIV tat and morphine-mediated neuronal dysfunction","volume":"3","author":"Hu","year":"2012","journal-title":"Cell Death Dis."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1007\/s13365-016-0451-6","article-title":"Exosome-associated release, uptake, and neurotoxicity of HIV-1 tat protein","volume":"22","author":"Rahimian","year":"2016","journal-title":"J. Neurovirol."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s13365-015-0397-0","article-title":"Microglia-derived hiv NEF+ exosome impairment of the blood-brain barrier is treatable by nanomedicine-based delivery of nef peptides","volume":"22","author":"Raymond","year":"2016","journal-title":"J. Neurovirol."}],"container-title":["Brain Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3425\/7\/3\/25\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:29:00Z","timestamp":1760207340000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3425\/7\/3\/25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,23]]},"references-count":249,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,3]]}},"alternative-id":["brainsci7030025"],"URL":"https:\/\/doi.org\/10.3390\/brainsci7030025","relation":{},"ISSN":["2076-3425"],"issn-type":[{"value":"2076-3425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,23]]}}}